Your browser doesn't support javascript.
loading
The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.
Spangle, Jennifer M; Roberts, Thomas M; Zhao, Jean J.
Afiliação
  • Spangle JM; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA. Electronic address: jennifer_spangle@dfci.harvard.edu.
  • Roberts TM; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.
  • Zhao JJ; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA. Electronic address: jean_zhao@dfci.harvard.edu.
Biochim Biophys Acta Rev Cancer ; 1868(1): 123-131, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28315368

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Epigênese Genética / Proteínas Proto-Oncogênicas c-akt / Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Epigênese Genética / Proteínas Proto-Oncogênicas c-akt / Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2017 Tipo de documento: Article